Crossmark

Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma

Crossref DOI link: https://doi.org/10.1186/s12967-020-02243-w

Published Online: 2020-02-10

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Padthaisong, Sureerat

Thanee, Malinee

Namwat, Nisana

Phetcharaburanin, Jutarop

Klanrit, Poramate

Khuntikeo, Narong

Titapun, Attapol

Sungkhamanon, Sakkarn

Saya, Hideyuki

Loilome, Watcharin https://orcid.org/0000-0001-8572-5577
Funding

Funding for this research was provided by:

Thailand Research Fund (PHD/0084/2560)

Khon Kaen University (IN62142)

Cholangiocarcinoma Screening and Care Program (CASCAP-09)

Thailand Research Fund (RSA5980013)
License Information

Text and Data Mining valid from 2020-02-10

Version of Record valid from 2020-02-10
More Information

Article History

Received: 28 September 2019

Accepted: 27 January 2020

First Online: 10 February 2020

Ethics approval and consent to participate

: This study was approved by the Human Research Ethics Committees, Khon Kaen University, Thailand (HE611412).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below